8-Bromo-7-(2-butyn-1-yl)-3-methylxanthine CAS 666816-98-4 Linagliptin Purity Eadar-mheadhanach ≥99.0% (HPLC) Factaraidh
Solaraiche neach-dèanamh Linagliptin agus eadar-mheadhanan co-cheangailte:
Linagliptin CAS 668270-12-0
Nucleus Pàrant Eadar-mheadhanach Linagliptin CAS 853029-57-9
8-Bromo-3-Methylxanthine CAS 93703-24-3
8-Bromo-7- (2-butyn-1-il)-3-methylxanthine CAS 666816-98-4
2-(Chloromethyl)-4-Methylquinazoline CAS 109113-72-6
(R)-3-(Boc-Amino)piperidine CAS 309956-78-3
(R) -(-)-3-Aminopiperidine Dihydrochloride CAS 334618-23-4
1-Bromo-2-Butyne CAS 3355-28-0
Ainm Ceimigeach | 8-Bromo-7-(2-butyn-1-il)-3-methylxantine |
Co-fhaclan | 8-Bromo-7- (2-butyn-1-yl)-3,7-dihydro-3-methyl-1H-purine-2,6-dione;Eadar-mheadhanach Linagliptin C |
Àireamh CAS | 666816-98-4 |
Àireamh CAT | RF-PI497 |
Inbhe Stoc | Ann an stoc, ìre toraidh suas gu tonna |
Foirmle Molecular | C10H9BrN4O2 |
Cuideam Molecular | 297.11 |
Rubha leaghaidh | 285 ℃ |
Brand | Ceimigeach Ruifu |
Nì | Sònrachaidhean |
Coltas | Pùdar Geal gu Off-White |
Uisge (KF) | ≤0.50% |
Fuigheall air Ignition | ≤0.50% |
Purity / Modh Mion-sgrùdadh | ≥99.0% (HPLC) |
Max Impurity Singilte | ≤0.50% |
Fuasglaidhean air fhàgail | |
Ethanol | ≤5000ppm |
DMF | ≤3000ppm |
Inbhe deuchainn | Inbhe Iomairt |
Cleachdadh | Eadar-mheadhanach airson Linagliptin (CAS: 668270-12-0) |
Pacaid: Botal, poca foil alùmanum, 25kg / druma cairt-bhòrd, no a rèir riatanas luchd-ceannach.
Suidheachadh stòraidh:Bùth ann an soithichean dùinte ann an àite fionnar is tioram;Dìon bho sholas is taiseachd.
![1](https://a395.goodao.net/uploads/15.jpg)
![](https://a395.goodao.net/uploads/23.jpg)
Tha 8-Bromo-7- (2-butyn-1-yl) -3-methylxanthine (CAS: 666816-98-4) na eadar-mheadhanach airson Linagliptin (CAS: 668270-12-0).Tha Linagliptin na neach-dìon beòil, fìor roghnach de dipeptidyl peptidase-4 agus is e a ’chiad àidseant den chlas aige a chaidh a chuir às gu ìre mhòr tro shlighe neo-dhruim-altachain.Tha Linagliptin air a chomharrachadh airson a chleachdadh aon uair san latha airson làimhseachadh inbhich le tinneas an t-siùcair seòrsa 2 mellitus.Chaidh Linagliptin aontachadh le FDA na SA sa Chèitean 2011 airson làimhseachadh tinneas an t-siùcair Type 2 còmhla ri daithead agus eacarsaich.
-
8-Bromo-7-(2-butyn-1-yl)-3-methylxanthine CAS 6...
-
Linagliptin CAS 668270-12-0 Purity ≥99.0% (HPLC ...
-
Nucleus Pàrant Eadar-mheadhanach Linagliptin CAS 853...
-
8-Bromo-3-Methylxanthine CAS 93703-24-3 Linagli ...
-
2-(Chloromethyl)-4-Methylquinazoline CAS 109113...
-
(R) -3-(Boc-Amino) pìobaire CAS 309956-78-3 Lin ...
-
(R) -(-)-3-Aminopiperidine Dihydrochloride CAS 3...
-
1-Bromo-2-Butyne CAS 3355-28-0 Purity ≥99.0% (G...